"WE're disappointed with the courts ruling to discontinue adipose stem cell treatments in the US. While we believe there is substantial evidence to prove the efficacy of this protocol, we must immediately comply with the court as we review the decision.
US Stem Cell INC and US Stem Cell Clinic will continue to operate business as usual, but we will no longer offer the adipose/SVF procedure.
We're hopeful the FDA will strive to work with the industry to establish clarity around life-saving innovations in regenerative medicine."
Market Data 
Markets 
AI
